Tongjitang Chinese Medicines Company

Tongjitang Chinese Medicines Company, through its subsidiaries, develops, manufactures, markets, and sells traditional Chinese medicine, nutritional products, and Tibetan recipe-originated plant-based medicines in China. It also involves in the distribution and retail sale of medicines. The company offers Xianling Gubao for the treatment of osteoporosis, osteoarthritis, ischemic bone necrosis, and bone fractures; Zaoren Anshen capsules for the treatment of insomnia; and moisturizing and anti-itching capsules for the treatment of inflammatory skin conditions. It also provides Dianbaizhu Syrup for the treatment of vertigo; Compound Glycyrrhiza oral solution for the treatment of upper respiratory infections; Jiao Ti Guo Jiao Bi capsules that prevent gastritis and ulcers; Bu Shen Yi Lao capsules, which improve memory, breathing, hearing, and general malaise; Xin Nao Kang capsules for the treatment of stroke and coronary artery disease; Jincishen Mixture, an ancillary for treatment of cancer; Heiguteng capsules for the treatment of rheumatoid arthritis; Chongcao Qingfei capsules for the treatment of Chronic Obstructive Pulmonary disease; Fengshi Gutong capsules for the treatment of rheumatoid arthritis; and Jingshu Granules for treatment of degenerative osteoarthritis. Tongjitang’s pipeline stage products include Jing Tong Ting for the treatment of menstrual pain, which completed phase III clinical trial; Yushuda Tablets for depression, which completed phase III clinical trial; Da An Granules, a phase III stage product for anxiety; Dan Xian Kang Gu Capsules that are under phase III clinical trial; Methylthioninium Chloride and Procainimide Injection; OA-008, a pre-clinical stage product for Osteoarthritis; and Xianling Gubao Chewable Tablets for the treatment of Osteoporosis that are in pre-clinical stage. It sells its products through third-party distributors. The company was founded in 1995 and is headquartered in Shenzhen, China. As of October 23, 2013, Tongjitang Chinese Medicines Company operates as a subsidiary of Winteam Pharmaceutical Group Limited.